Investors resorted to profit-taking, particularly, in banking shares amid fresh worries that the soon to be introduced methodology to compute lending rates could squeeze margins of several lenders. | Subscribe To Our Free Newsletter |
No pains, only gains! Crompton Greaves, Bal Pharma, 68 others hit 52-week high
Investors resorted to profit-taking, particularly, in banking shares amid fresh worries that the soon to be introduced methodology to compute lending rates could squeeze margins of several lenders. 